2013
DOI: 10.1074/jbc.m113.495366
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets

Abstract: Background: Apolipoproteins (apo) C-I and C-III regulate plasma triglyceride metabolism by inhibition of lipoprotein lipase (LPL) activity. Results: ApoC-I or apoC-III prevents LPL from binding to lipid droplets. This results in inhibition of LPL. Conclusion: Inhibition of LPL activity by apoC-I and apoC-III is due to displacement of LPL from lipid droplets. Significance: Our proposed mechanism explains several effects of these apolipoproteins on lipoprotein metabolism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
131
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 147 publications
(142 citation statements)
references
References 72 publications
10
131
0
1
Order By: Relevance
“…ApoC-III retards LPL-mediated TRL processing, limiting access of LPL to TRL substrates (33). In transgenic mice that overexpress human apoC-III, TRL processing by the LPL-GPIHBP1 complex is impaired (34), causing hypertriglyceridemia.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…ApoC-III retards LPL-mediated TRL processing, limiting access of LPL to TRL substrates (33). In transgenic mice that overexpress human apoC-III, TRL processing by the LPL-GPIHBP1 complex is impaired (34), causing hypertriglyceridemia.…”
Section: Resultsmentioning
confidence: 99%
“…suggesting that the higher LPL activity in BAT during cold exposure (35,36) outweighs the ability of apoC-III to limit LPL accessibility to triglyceride substrates (33,34). We also examined mice deficient in both apoC-III and GPIHBP1 (Gpihbp1 −/− Apoc3 −/− ).…”
Section: Resultsmentioning
confidence: 99%
“…On the other hand, the role of apoC-I on TRLs has solely been examined in vitro and in murine models. apoC-I was found to inhibit the binding of LPL to lipid emulsions, decreasing TG hydrolysis and rendering unbound-LPL more prone to inactivation (41). ApoE knockout mice overexpressing human apoC-I have reduced uptake of 3 H-TG-derived NEFAs from intravenously administered 3 H-VLDL-like particles only in WAT (21).…”
Section: Direct Effect Of Human Apoc-i On In Situ Lpl Activity In 3t3mentioning
confidence: 99%
“…apo-CII is an obligatory activating co-factor of LPL whilst apo-CI and apo-CIII are inhibitors [75].…”
Section: Lipoprotein Lipase Mediated Myocardial Tag Uptakementioning
confidence: 99%
“…TGRLPs bind and stabilise LPL and protect it from angptl-4 inhibition; apo-CI and CIII inhibit this stabilisation [75]. Apo-E inhibits [76] and apo-AV stimulates [77] LPL and plasma TAG clearance.…”
Section: Lipoprotein Lipase Mediated Myocardial Tag Uptakementioning
confidence: 99%